✦ LIBER ✦

A novel c-Met inhibitor, MK8033, synergizes with carboplatin plus paclitaxel to inhibit ovarian cancer cell growth

✍ Scribed by Lancaster, Johnathan

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A novel cMET inhibitor, MK8033, potentia

✍ Marchion, D.; Ramirez-Diaz, I.; Bou Zgheib, N.; Xiong, Y.; Stickles, X.; Judson 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 59 KB

MK2206, a selective AKT inhibitor, modul

✍ N. Bou Zgheib; D. Marchion; Y. Xiong; X. Stickles; P. Judson; A. Hakam; J. Gonza 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 65 KB